Coincentral

Coincentral

Coincentral is a leading publication focused on cryptocurrency news and education. It provides investors with easy to understand guides and market analysis, serving as a trusted resource for navigating the digital asset space.

Coincentral's Articles

Olema Pharmaceuticals (OLMA) Stock Rises 9% After Q4 Earnings Beat

Olema Pharmaceuticals (OLMA) Stock Rises 9% After Q4 Earnings Beat

TLDR Olema Pharmaceuticals (OLMA) jumped 8.5% on Monday after beating Q4 EPS estimates by $0.01, reporting a loss of $0.50 vs. the expected $0.51. The company posted

Ripple Buyback Debate Grows as Schwartz Defends XRP

Ripple Buyback Debate Grows as Schwartz Defends XRP

TLDR Ripple repurchased $750 million of its shares at a $50 billion valuation. David Schwartz rejected claims that the buyback harms XRP holders. Schwartz argued

XRPL Upgrades Strengthen XRP for RWA Tokenization Push

XRPL Upgrades Strengthen XRP for RWA Tokenization Push

TLDR The XRPL activated six protocol upgrades between February 2024 and February 2026 to support compliant RWA tokenization. The Clawback feature allows issuers

JPMorgan Chase Opens Door to Bitcoin and Ethereum as Loan Collateral for Clients

JPMorgan Chase Opens Door to Bitcoin and Ethereum as Loan Collateral for Clients

TLDR CNBC reported JPMorgan is allowing Bitcoin and Ethereum as collateral in parts of its trading business. Reports said the program is in early stages and is

Bitpanda Eyes €5B Frankfurt IPO in Crypto Listing Wave

Bitpanda Eyes €5B Frankfurt IPO in Crypto Listing Wave

TLDR Bitpanda plans to list on the Frankfurt Stock Exchange at a targeted €4–5 billion valuation in 2026. The company expanded its platform to over 10,000 stocks

Bitcoin Whales Signal Rebound as BTC Eyes $100K

Bitcoin Whales Signal Rebound as BTC Eyes $100K

TLDR Bitcoin held above $70,000 as whale activity reached a six-year high on CryptoQuant data. The Exchange Whale Ratio surged to levels last seen in the previous

Structure Therapeutics (GPCR) Stock Surges 10% as GLP-1 Pill Outperforms Lilly and Novo

Structure Therapeutics (GPCR) Stock Surges 10% as GLP-1 Pill Outperforms Lilly and Novo

TLDR Structure Therapeutics’ GLP-1 pill aleniglipron showed 16.3% placebo-adjusted weight loss at 44 weeks in its Phase 2 ACCESS II trial Results beat competing

Eaton (ETN) Stock Rises 3% After Jefferies Reinstates Buy Rating

Eaton (ETN) Stock Rises 3% After Jefferies Reinstates Buy Rating

TLDR Jefferies analyst Stephen Volkmann reinstated a Buy rating on Eaton (ETN) with a $430 price target on Sunday The call follows Eaton completing its acquisition

ServiceNow (NOW) Stock Drops 23% YTD — BNP Paribas Says Buy the Dip

ServiceNow (NOW) Stock Drops 23% YTD — BNP Paribas Says Buy the Dip

TLDR BNP Paribas upgraded ServiceNow (NOW) from Neutral to Outperform on March 16, 2026. The stock is down 23% year-to-date, which BNP sees as a buying opportunity

When Crypto Spending Services Go Offline: Why Redundancy Matters for Everyday Bitcoin Users

When Crypto Spending Services Go Offline: Why Redundancy Matters for Everyday Bitcoin Users

For years, one of the most practical ways to spend cryptocurrency has been through digital gift cards. Platforms that convert Bitcoin, stablecoins, and other digital